Renault SA RNO.PA
Composite 48/100; the shares have moved about 34% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Balance-sheet strength ranks 19/100 — a strong mark against it.
Income ranks 94/100 — a strong point in its favour. Valuation ranks 87/100 — a strong point in its favour. Growth ranks 64/100 — a moderate point in its favour.
Balance-sheet strength ranks 19/100 — a strong mark against it. Quality ranks 27/100 — a moderate mark against it. Momentum ranks 40/100 — a slight mark against it.
What the company does Renault SA (RNO.PA) designs, manufactures, and sells passenger cars, light commercial vehicles, and mobility solutions under brands like Renault, Dacia, and Alpine. Its segments include Automotive, Sales Financing (Mobilize Financial Services), and Mobility Services (Mobilize Beyond Automotive).
Key financials Renault reports weak profitability metrics: ROE -40.4%, ROA 1.8%, ROCE -25.2%, and net margins of -18.9%. Revenue grew 3.4% but EPS fell -39.4%. Leverage is high (Debt/Equity 3.16) with a current ratio of 1.02 and interest coverage of -15.06.
Stock health The stock shows poor quality (Sideravia Overall 32.2) but strong income (94.3) and valuation (67.5) scores. Momentum is weak (32.9), with a 12m return of -6.70% and RSI(14) at 61.60.
Price vs fair value The stock trades at a **discount** of 83.90% to our fair-value estimate of 51.33 and a **discount** of 37.23% to the 12-month target of 38.30. - Simply Wall St highlights potential undervaluation amid reaffirmed 2026 guidance (Simply Wall St, 2026-07-31). - H1 2026 earnings call noted revenue growth of 9% (GuruFocus.com, 2026-07-31). - WSJ reports cost-cutting efforts are bearing fruit (The Wall Street Journal, 2026-07-29). - Wards Auto flags pressure on Dacia from China imports (Wards Auto, 2026-07-29).
Looking forward Analysts cite 2026 guidance and cost-cutting as catalysts, but weak profitability and legal risks (Dieselgate trial) temper optimism. Forward P/E of 8.16 and FCF yield of 9.5% suggest valuation support, though momentum remains subdued.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.